Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Fluorodeoxyglucose F18 × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 9 CNS 2 Gastrointestinal 1 Breast 1

Conditions

Breast Neoplasms 34 Stomach Neoplasms 4 Breast Neoplasms, Male 4 Salivary Gland Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Renal Cell 3 Carcinoma, Non-Small-Cell Lung 3 Brain Neoplasms 3 Tongue Neoplasms 2 Thyroid Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Colorectal Neoplasms 2 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 24 pembrolizumab 22 Docetaxel 20 Capecitabine 18 Trastuzumab 16 Fulvestrant 14 Cyclophosphamide 14 Lapatinib 13 Anastrozole 12 Letrozole 10 Carboplatin 10 Therapeutics 9 Radiotherapy 9 Doxorubicin 9 Exercise 8 Cisplatin 8 Blood Specimen Collection 8 palbociclib 7 Nivolumab 7 Gemcitabine 7 Bevacizumab 7 liposomal doxorubicin 6 exemestane 6 Vinorelbine 6 Tamoxifen 6 Fluorouracil 6 atezolizumab 5 abemaciclib 5 Methods 5 Irinotecan 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00708045 2024-03-15

Chemobrain

University of Utah

Phase 1 Completed

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡